** Shares of Fisher & Paykel Healthcare FPH.NZ rise as
much as 5.6% to NZ$33.90, their highest since late-November 2021
** Medical equipment maker expects FY25 NPAT in the range of
NZ$320 mln ($196.51 mln) to NZ$370 mln vs previous forecast of
between NZ$310 mln and NZ$360 mln
** Maintains FY25 revenue forecast of NZ$1.9 bln to NZ$2.0
bln
** Says year-to-date has begun strongly across all products
and regions
** Stock top gainer on the NZ 50 benchmark index .NZ50
** As of last close, stock up 36% YTD
($1 = 1.6284 New Zealand dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))